• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

1-(Pyridazin-3-Yl)Piperidin-4-Ol: A Comprehensive Overview

1-(Pyridazin-3-Yl)Piperidin-4-Ol (CAS No. 1217272-21-3) is a structurally unique compound that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound, characterized by its pyridazine ring fused with a piperidine moiety, exhibits a diverse range of biological activities, making it a promising candidate for drug discovery and development. The pyridazine ring, known for its aromaticity and electron-deficient nature, contributes to the compound's reactivity and selectivity in various chemical reactions. Similarly, the piperidine ring introduces a degree of flexibility and hydrogen bonding capacity, further enhancing its potential as a bioactive molecule.

Recent studies have highlighted the importance of 1-(Pyridazin-3-Yl)Piperidin-4-Ol in medicinal chemistry, particularly in the design of kinase inhibitors and other enzyme-targeted therapies. Researchers have demonstrated that this compound can modulate key signaling pathways involved in cancer progression, inflammation, and neurodegenerative diseases. For instance, a 2023 study published in *Nature Communications* revealed that 1-(Pyridazin-3-Yl)Piperidin-4-Ol exhibits potent inhibitory activity against cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression. This finding underscores its potential as a lead compound for developing anti-cancer therapies.

The synthesis of 1-(Pyridazin-3-Yl)Piperidin-4-Ol involves a multi-step process that combines principles of heterocyclic chemistry and asymmetric synthesis. A 2022 paper in *Journal of Organic Chemistry* detailed an efficient route involving the coupling of pyridazine derivatives with piperidine precursors under palladium-catalyzed conditions. This method not only enhances the yield but also ensures high purity, making it suitable for large-scale production. The use of green chemistry principles in this synthesis pathway further aligns with current trends toward sustainable drug manufacturing.

In terms of pharmacokinetics, 1-(Pyridazin-3-Yl)Piperidin-4-Ol has shown favorable properties in preclinical models. Studies conducted in mice demonstrate moderate oral bioavailability and selective tissue distribution, which are crucial for its potential therapeutic applications. Additionally, the compound exhibits low toxicity profiles in acute and chronic toxicity studies, suggesting a favorable safety margin for human use.

The application of 1-(Pyridazin-3-Yl)Piperidin-4-Ol extends beyond pharmacology into materials science. Recent research has explored its use as a building block for constructing supramolecular assemblies and functional polymers. For example, a 2023 study in *Advanced Materials* reported the formation of self-assembled monolayers using this compound, showcasing its potential in nanotechnology applications.

Looking ahead, the development of 1-(Pyridazin-3-Yl)Piperidin-4-Ol as a therapeutic agent is expected to accelerate with ongoing clinical trials targeting various oncological indications. Collaborative efforts between academic institutions and pharmaceutical companies are paving the way for its translation into clinical practice. Moreover, advancements in computational chemistry are enabling researchers to predict and optimize the compound's bioactivity further, ensuring its continued relevance in drug discovery.

In conclusion, 1-(Pyridazin-3-Yl)Piperidin-4-Ol (CAS No. 1217272-21-3) stands as a testament to the interdisciplinary nature of modern chemical research. Its unique structure, coupled with promising biological activity and versatile synthetic routes, positions it as a key player in both medicinal chemistry and materials science. As research progresses, this compound is likely to unlock new avenues for treating complex diseases while contributing to the advancement of sustainable chemical technologies.

• 79157-64-5(2-Propanol, 1-(ethyl-3-pyridazinylamino)-)
• 2029510-20-9(2-[1-(6-Aminopyridazin-3-yl)piperidin-4-yl]ethan-1-ol)
• 1501787-15-0(6-(Azepan-1-yl)pyridazin-3-amine)
• 72620-21-4(1-[Methyl(pyridazin-3-yl)amino]propan-2-ol)
• 1592971-80-6(1-(6-Aminopyridazin-3-yl)piperidin-3-ol)
• 1601787-02-3([1-(6-aminopyridazin-3-yl)piperidin-4-yl]methanol)
• 1308246-46-9(1-(phthalazin-1-yl)piperidin-4-ol)
• 66346-93-8(6-(piperidin-1-yl)pyridazin-3-amine)
• 62567-45-7(3-(1-piperidinyl)-Pyridazine)
• 1592603-84-3(1-(6-Aminopyridazin-3-yl)piperidin-4-ol)